Lee Nara, Baek Woo Yeol, Choi Yun Rak, Joo Dong Jin, Lee Won Jai, Hong Jong Won
Department of Plastic & Reconstructive Surgery, Yonsei University, College of Medicine, Seoul, Korea.
Institute for Human Tissue Restoration, Yonsei University, College of Medicine, Seoul, Korea.
Arch Plast Surg. 2023 Aug 2;50(4):415-421. doi: 10.1055/a-2059-5570. eCollection 2023 Jul.
The revision of the Korea Organ Transplantation Act (KOTA) in 2018 included hand/arm among the organs that can be transplanted. The first hand transplantation since the revision of KOTA took place in January 2021. A 62-year-old male patient experienced hand amputation on July 13, 2018, by a catapult injury. The patient first visited our institute 3 months after the injury. After serial interviews and an overall evaluation, the patient was registered on the hand transplantation waiting list in January 2020. On January 9, 2021, the patient underwent hand transplantation at the right distal forearm level. The total operation time was 17 hours 15 minutes, and the cold ischemic time was 4 hours 9 minutes. Postoperative immunosuppression was administered based on the protocol used for kidney transplantation. Two acute rejection episodes occurred, on postoperative days 33 and 41. Both rejection episodes were reversible with rescue therapy of a higher tacrolimus trough level, steroid pulse therapy, and topical immunosuppressants. Controlled passive range of motion exercise was started on postoperative day 10. Dynamic splint was applied on postoperative day 18. At 1 year, graft maintenance and functional improvement were satisfactory, and the patient showed a Disabilities of Arm, Shoulder and Hand score of 25.8. We successfully performed the first hand transplantation surgery under the KOTA amendment. It came from the organic and effective cooperation of plastic, orthopaedic, and transplantation departments and we believe it will guarantee the future ongoing success.
2018年修订的《韩国器官移植法》(KOTA)将手/手臂纳入可移植器官范畴。KOTA修订后的首例手部移植手术于2021年1月进行。一名62岁男性患者于2018年7月13日因弹弓伤导致手部截肢。患者受伤3个月后首次前来我院就诊。经过一系列访谈和全面评估,该患者于2020年1月被列入手部移植等待名单。2021年1月9日,患者在右前臂远端水平接受了手部移植手术。总手术时间为17小时15分钟,冷缺血时间为4小时9分钟。术后免疫抑制按照肾移植所用方案进行。术后第33天和第41天发生了两次急性排斥反应。通过提高他克莫司谷浓度、类固醇冲击治疗和局部免疫抑制剂的挽救治疗,两次排斥反应均可逆。术后第10天开始进行控制性被动活动度锻炼。术后第18天应用动力支具。1年后,移植物维持情况和功能改善令人满意,患者的手臂、肩部和手部功能障碍评分(Disabilities of Arm, Shoulder and Hand score)为25.8。我们在KOTA修正案下成功实施了首例手部移植手术。这得益于整形、骨科和移植科室的有机有效合作,我们相信这将确保未来手术持续取得成功。